Top Markets
Coin of the day
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
株式のランク #24699
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
株価
$0.95011029
最終同期: 2023-06-28
時価総額
$57.72M
変化(1日)
8.53%
変化(1年)
0.00%
FR
取引 ERYTECH Pharma S.A. (ERYP)

カテゴリー

ERYTECH Pharma S.A.(ERYP)の株価履歴
終値の最高値: $0.90 (2023-06-01)

終値の最安値: $14.08 (2013-05-01)
ERYTECH Pharma S.A. の株価履歴(2013 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2023 73.43%
2022 -78.67%
2021 -73.09%
2020 82.31%
2019 -31.19%
2018 -67.04%
2017 59.44%
2016 -51.05%
2015 -15.86%
2014 158.90%
2013 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$551.23 38.69%
US
$1.06K 59.04%
NL
$146.66 459.34%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH